MENU
+Compare
OGEN
Stock ticker: ASE
AS OF
Dec 23, 10:55 AM (EDT)
Price
$0.35
Change
-$0.01 (-2.78%)
Capitalization
4.35M

OGEN Oragenics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for OGEN with price predictions
Dec 20, 2024

OGEN saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for OGEN moved out of overbought territory on December 12, 2024. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 33 similar instances where the indicator exited the overbought zone. In of the 33 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 20, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on OGEN as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OGEN broke above its upper Bollinger Band on December 05, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for OGEN just turned positive on November 25, 2024. Looking at past instances where OGEN's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

OGEN moved above its 50-day moving average on December 19, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OGEN crossed bullishly above the 50-day moving average on December 11, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OGEN advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.927) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). OGEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OGEN is expected to report earnings to fall 95.05% to -5 cents per share on May 15

Oragenics OGEN Stock Earnings Reports
Q1'23
Est.
$-0.05
Q4'22
Beat
by $1.39
Q3'22
Beat
by $0.02
Q2'22
Beat
by $0.01
Q1'22
Missed
by $0.03
The last earnings report on February 17 showed earnings per share of -100 cents, beating the estimate of -240 cents. With 17.42K shares outstanding, the current market capitalization sits at 4.35M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1990 Main Street
Phone
+1 813 286-7900
Employees
5
Web
https://www.oragenics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNDY242.4917.80
+7.92%
monday.com Ltd
HTZ3.420.15
+4.59%
Hertz Global Holdings
ECBK15.050.13
+0.87%
ECB Bancorp
RGR34.93-0.30
-0.85%
Sturm Ruger & Company
TPET1.11-0.36
-24.49%
Trio Petroleum Corp

OGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-5.53%
ATHA - OGEN
33%
Loosely correlated
+5.11%
SRPT - OGEN
30%
Poorly correlated
-0.42%
CHRS - OGEN
27%
Poorly correlated
+2.70%
RNA - OGEN
26%
Poorly correlated
+2.48%
FBRX - OGEN
25%
Poorly correlated
+3.64%
More